2020
DOI: 10.1016/j.compbiolchem.2020.107271
|View full text |Cite
|
Sign up to set email alerts
|

Utilisation of the OliveNet™ Library to investigate phenolic compounds using molecular modelling studies in the context of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 82 publications
0
3
0
Order By: Relevance
“…In the same model, treatment with the aforementioned compounds and commercial preparation of OL exerted a stronger protection against Aβ42-, Cu-Aβ42-, or L-DOPA-Aβ42-induced neurotoxicity, manifesting an increase in cell viability [40]. In accordance with a computational binding affinity test, the neurotoxicity reduction mentioned above may be attributed to the ability of OLE, HT, LU, VB, and QUE, as well as their derivatives, to strongly bind to the hairpin-turn of the Aβ 1-40 and Aβ 1-42 monomers and the subsequent reduction in Aβ fibrillization [41]. On the other hand, β-secretase site-1 (BACE-1) is involved in the generation of the Aβ aggregation since it participates in the amyloidogenic processing of the amyloid precursor protein (APP).…”
Section: Effects On Aβ Aggregationmentioning
confidence: 65%
“…In the same model, treatment with the aforementioned compounds and commercial preparation of OL exerted a stronger protection against Aβ42-, Cu-Aβ42-, or L-DOPA-Aβ42-induced neurotoxicity, manifesting an increase in cell viability [40]. In accordance with a computational binding affinity test, the neurotoxicity reduction mentioned above may be attributed to the ability of OLE, HT, LU, VB, and QUE, as well as their derivatives, to strongly bind to the hairpin-turn of the Aβ 1-40 and Aβ 1-42 monomers and the subsequent reduction in Aβ fibrillization [41]. On the other hand, β-secretase site-1 (BACE-1) is involved in the generation of the Aβ aggregation since it participates in the amyloidogenic processing of the amyloid precursor protein (APP).…”
Section: Effects On Aβ Aggregationmentioning
confidence: 65%
“…The study found that phenolic ligands bind strongly to the hairpin turn of Aβ1‐40 and Aβ1‐42 monomers and also identified binding sites in the tau fibril protein structures. New lead compounds, including cyanidin‐3‐ O ‐rutinoside, luteolin‐4′‐ O ‐rutinoside, luteolin‐7,4‐ O ‐diglucoside, oleuricine A, isorhoifolin, and luteolin‐7‐ O ‐rutinoside, were predicted, which could lead to the development and evaluation of novel compounds with potential efficacy against Alzheimer's disease [28] . It has been reported that hesperidin had useful effects on serum TNF‐ α , IL‐6, and hs‐CRP in the supplemented group.…”
Section: Discussionmentioning
confidence: 99%
“…New lead compounds, including cyanidin-3-O-rutinoside, luteolin-4'-O-rutinoside, luteolin-7,4-O-diglucoside, oleuricine A, isorhoifolin, and luteolin-7-O-rutinoside, were predicted, which could lead to the development and evaluation of novel compounds with potential efficacy against Alzheimer's disease. [28] It has been reported that hesperidin had useful effects on serum TNFα, IL-6, and hs-CRP in the supplemented group. Obtaining results assists the anti-inflammatory effects of hesperidin in DM.…”
Section: Quantitative Analysis Of Secondary Metabolitesmentioning
confidence: 94%